Anti-inflammatory actions of Caesalpinin M2 in experimental colitis as a selective glucocoricoid receptor modulator
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 150, 150-159
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81330079, 81573446, 31670359, 81374066)
- Liaoning High Education Science Projects (201610163L16)
- Project of State Key Laboratory of Bioactive Substance and Function of Natural Medicines (GTZK201703)
This publication has 35 references indexed in Scilit:
- Diptoindonesin G promotes ERK-mediated nuclear translocation of p-STAT1 (Ser727) and cell differentiation in AML cellsCell Death & Disease, 2017
- The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in miceBiochemical Pharmacology, 2016
- Simultaneous identification and analysis of cassane diterpenoids in Caesalpinia minax Hance by high‐performance liquid chromatography with quadrupole time‐of‐flight mass spectrometryJournal of Separation Science, 2015
- Anti-inflammation furanoditerpenoids from Caesalpinia minax HancePhytochemistry, 2015
- Suppression of NF-κB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinelloneToxicology and Applied Pharmacology, 2014
- Environmental Risk Factors for Inflammatory Bowel Diseases: A ReviewDigestive Diseases and Sciences, 2014
- Seven new cassane furanoditerpenes from the seeds of Caesalpinia minaxFitoterapia, 2014
- Simplified proteomics approach to discover protein–ligand interactionsProtein Science, 2012
- A review on cassane and norcassane diterpenes and their pharmacological studiesFitoterapia, 2012
- Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: Survival of the fittest regulator of the immune system?Brain, Behavior, and Immunity, 2010